83 FR 5112 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 24 (February 5, 2018)

Page Range		5112-5113
FR Document		2018-02156

Federal Register, Volume 83 Issue 24 (Monday, February 5, 2018)

[Federal Register Volume 83, Number 24 (Monday, February 5, 2018)]
[Notices]
[Pages 5112-5113]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-02156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with grant applications 
and/or contract proposals, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, TEP-8: Non-Mouse Reagents for Novel Therapeutics.
    Date: February 23, 2018.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-11: Cancer Imaging Tools.
    Date: March 8, 2018.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-10: Immunoassay Development.
    Date: March 15, 2018.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2W030, Rockville, MD 20850 (Telephone Conference 
Call).

[[Page 5113]]

    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609, Medical 
Center Drive, Room 7W424, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-4: NCI Clinical and Translational Exploratory/
Developmental Studies.
    Date: April 24, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W246, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609, Medical 
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-5.
    Date: April 26, 2018.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Reed A. Graves, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-6384, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 30, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02156 Filed 2-2-18; 8:45 am]
 BILLING CODE 4140-01-P

5112 Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices

Contact Person: Paula Elyse Schauwecker, 93.333, Clinical Research, 93.306, 93.333, DEPARTMENT OF HEALTH AND
Ph.D., Scientific Review Officer, National 93.337, 93.393–93.396, 93.837–93.844, HUMAN SERVICES
Institutes of Health, Center for Scientific 93.846–93.878, 93.892, 93.893, National
Review, 6701 Rockledge Drive, Room 5211, Institutes of Health, HHS) National Institutes of Health
Bethesda, MD 20892, 301–760–8207,
Dated: January 30, 2018.
schauweckerpe@csr.nih.gov. National Cancer Institute; Notice of
Name of Committee: Center for Scientific Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Closed Meetings
Review Special Emphasis Panel; Small
Business: Neuro/Psychopathology, Lifespan Committee Policy. Pursuant to section 10(d) of the
Development, and STEM Education. [FR Doc. 2018–02154 Filed 2–2–18; 8:45 am] Federal Advisory Committee Act, as
Date: March 5, 2018. BILLING CODE 4140–01–P amended, notice is hereby given of the
Time: 11:00 a.m. to 5:00 p.m. following meetings.
Agenda: To review and evaluate grant The meetings will be closed to the
applications.
Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND public in accordance with the
Rockledge Drive, Bethesda, MD 20892 HUMAN SERVICES provisions set forth in sections
(Virtual Meeting). 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Contact Person: Elia E. Femia, Ph.D., National Institutes of Health as amended. The grant applications
Scientific Review Officer, Center for and/or contract proposals and the
Scientific Review, National Institutes of Center for Scientific Review; Amended discussions could disclose confidential
Health, 6701 Rockledge Drive Room 3108, Notice of Meeting trade secrets or commercial property
Bethesda, MD 20892, 301–827–7189,
femiaee@csr.nih.gov. Notice is hereby given of a change in such as patentable material, and
the meeting of the Integrative Nutrition personal information concerning
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Immune and Metabolic Processes Study Section, individuals associated with grant
System Plasticity in Dental, Oral, and February 8, 2018, 8:00 a.m. to February applications and/or contract proposals,
Craniofacial Diseases. 9, 2018, 1:00 p.m., Westin Grand, 2350 the disclosure of which would
Date: March 5, 2018. M Street NW, Washington, DC 20037 constitute a clearly unwarranted
Time: 1:00 p.m. to 5:00 p.m. which was published in the Federal invasion of personal privacy.
Agenda: To review and evaluate grant Register on January 05, 2018, 83 FR 682.
applications. Name of Committee: National Cancer
The meeting will be held on February Institute Special Emphasis Panel, TEP–8:
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892 7, 2018, 5:00 p.m. and end on February Non-Mouse Reagents for Novel Therapeutics.
(Virtual Meeting). 8, 2018, 6:00 p.m. The meeting location Date: February 23, 2018.
Contact Person: Yi-Hsin Liu, Ph.D., remains the same. The meeting is closed Time: 10:00 a.m. to 4:00 p.m.
Scientific Review Officer, Center for to the public. Agenda: To review and evaluate contract
Scientific Review, National Institutes of proposals.
Dated: January 30, 2018. Place: National Cancer Institute, Shady
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435– Sylvia L. Neal, Grove, 9609 Medical Center Drive, Room
1781, liuyh@csr.nih.gov. Program Analyst, Office of Federal Advisory 7W108, Rockville, MD 20850 (Telephone
Committee Policy. Conference Call).
Name of Committee: Center for Scientific Contact Person: Clifford W. Schweinfest,
Review Special Emphasis Panel; Member [FR Doc. 2018–02151 Filed 2–2–18; 8:45 am] Ph.D., Scientific Review Officer, Special
Conflict: GI Physiology and Pathology. BILLING CODE 4140–01–P Review Branch, Division of Extramural
Date: March 5, 2018. Activities, National Cancer Institute, NIH,
Time: 1:00 p.m. to 4:00 p.m. 9609 Medical Center Drive, Room 7W108,
Agenda: To review and evaluate grant Bethesda, MD 20892–9750, 240–276–6343,
DEPARTMENT OF HEALTH AND
applications. schweinfestcw@mail.nih.gov.
Place: National Institutes of Health, 6701 HUMAN SERVICES
Name of Committee: National Cancer
Rockledge Drive, Bethesda, MD 20892
National Institutes of Health Institute Special Emphasis Panel; TEP–11:
(Telephone Conference Call).
Cancer Imaging Tools.
Contact Person: Meenakshisundar
Center for Scientific Review; Amended Date: March 8, 2018.
Ananthanarayanan, Scientific Review
Notice of Meeting Time: 10:00 a.m. to 6:00 p.m.
Officer, Center for Scientific Review,
Agenda: To review and evaluate contract
National Institutes of Health, 6701 Rockledge
Drive, Room 2178, Bethesda, MD 20892, 301–
Notice is hereby given of a change in proposals.
the meeting of the Molecular and Place: National Cancer Institute, Shady
827–6281, meena.ananthanarayanan@
Cellular Endocrinology Study Section, Grove, 9609 Medical Center Drive, Room
nih.gov. 7W030, Rockville, MD 20850 (Telephone
Name of Committee: Center for Scientific February 8, 2018, 8:00 a.m. to February
Conference Call).
Review Special Emphasis Panel; PAR Panel: 9, 2018, 5:00 p.m., Ritz-Carlton Hotel at Contact Person: Eduardo E. Chufan, Ph.D.,
Pilot Clinical Trials for The Spectrum of Pentagon City, 1250 South Hayes Street, Scientific Review Officer, Research
Alzheimer’s Disease. Arlington, VA 22202 which was Technology and Contract Review Branch,
Date: March 5, 2018. published in the Federal Register on Division of Extramural Activities, National
Time: 1:00 p.m. to 5:30 p.m. January 19, 2018, 83 FR PG 2806. Cancer Institute, NIH, 9609 Medical Center
Agenda: To review and evaluate grant This meeting will be held on February Drive, Room 7W254, Bethesda, MD 20892–
applications. 7, 2018 at 5:30 p.m. and end February 9750, 240–276–7975, chufanee@mail.nih.gov.
Place: National Institutes of Health, 6701 Name of Committee: National Cancer
Rockledge Drive, Bethesda, MD 20892 8, 2018 8:00 p.m. The meeting location
remains the same. The meeting is closed Institute Special Emphasis Panel; TEP–10:
(Telephone Conference Call).
sradovich on DSK3GMQ082PROD with NOTICES

Immunoassay Development.
Contact Person: Wind Cowles, Ph.D., to the public. Date: March 15, 2018.
Scientific Review Officer, Center for Dated: January 30, 2018. Time: 11:00 a.m. to 5:00 p.m.
Scientific Review, National Institutes of Agenda: To review and evaluate contract
Sylvia L. Neal,
Health, 6701 Rockledge Drive Room 3172, proposals.
Bethesda, MD 20892, 301–437–7872, Program Analyst, Office of Federal Advisory
Place: National Cancer Institute, Shady
cowleshw@csr.nih.gov. Committee Policy.
Grove, 9609 Medical Center Drive, Room
(Catalogue of Federal Domestic Assistance [FR Doc. 2018–02152 Filed 2–2–18; 8:45 am] 2W030, Rockville, MD 20850 (Telephone
Program Nos. 93.306, Comparative Medicine; BILLING CODE 4140–01–P Conference Call).

VerDate Sep<11>2014 18:08 Feb 02, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\05FEN1.SGM 05FEN1

Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices 5113

Contact Person: Yasuko Furumoto, Ph.D., National Cancer Institute Shady Grove, Research Service Awards for Research
Scientific Review Officer, Research Shady Grove, 9609 Medical Center Training; 93.273, Alcohol Research Programs;
Technology and Contract Review Branch, Drive, TE 406, Rockville, MD 20850 93.891, Alcohol Research Center Grants;
Division of Extramural Activities, National 93.701, ARRA Related Biomedical Research
which was published in the Federal and Research Support Awards, National
Cancer Institute, NIH, 9609, Medical Center
Drive, Room 7W424, Bethesda, MD 20892– Register on January 22, 2018, 83 FR Institutes of Health, HHS)
9750, 240–276–5287, yasuko.furumoto@ 3003.
The meeting notice is being amended Dated: January 30, 2018.
nih.gov.
to change the meeting times for the open Melanie J. Pantoja,
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4: NCI and closed sessions. The open session Program Analyst Office of Federal Advisory
Clinical and Translational Exploratory/ will he held from 1:00 p.m. to 3:10 p.m. Committee Policy.
Developmental Studies. The closed session will be held from [FR Doc. 2018–02157 Filed 2–2–18; 8:45 am]
Date: April 24, 2018. 3:25 p.m. to 4:25 p.m. The meeting is BILLING CODE 4140–01–P
Time: 10:00 a.m. to 5:00 p.m. partially closed to the public.
Agenda: To review and evaluate grant
applications. Dated: January 31, 2018.
DEPARTMENT OF HEALTH AND
Place: National Cancer Institute, Shady Melanie J. Pantoja, HUMAN SERVICES
Grove, 9609 Medical Center Drive, Room Program Analyst, Office of Federal Advisory
7W246, Rockville, MD 20850 (Telephone Committee Policy. National Institutes of Health
Conference Call). [FR Doc. 2018–02249 Filed 2–2–18; 8:45 am]
Contact Person: Jun Fang, Ph.D., Scientific National Heart, Lung, and Blood
BILLING CODE 4140–01–P
Review Officer, Research Technology and
Institute Notice of Meeting
Contract Review Branch, Division of
Extramural Activities, National Cancer Pursuant to section 10(d) of the
Institute, NIH, 9609, Medical Center Drive, DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as
Room 7W246, Bethesda, MD 20892–9750, HUMAN SERVICES
amended, notice is hereby given of a
240–276–5460, jfang@mail.nih.gov.
National Institutes of Health meeting of the National Heart, Lung,
Name of Committee: National Cancer and Blood Advisory Council.
Institute Special Emphasis Panel; TEP–5.
National Institute on Alcohol Abuse The meeting will be open to the
Date: April 26, 2018.
Time: 10:00 a.m. to 6:00 p.m. and Alcoholism; Notice of Closed public as indicated below, with
Agenda: To review and evaluate contract Meeting attendance limited to space available.
proposals. Individuals who plan to attend and
Place: National Cancer Institute, Shady Pursuant to section 10(d) of the need special assistance, such as sign
Grove, 9609 Medical Center Drive, Room Federal Advisory Committee Act, as language interpretation or other
7W106, Rockville, MD 20850 (Telephone amended, notice is hereby given of the reasonable accommodations, should
Conference Call). following meeting. notify the Contact Person listed below
Contact Person: Reed A. Graves, Ph.D., The meeting will be closed to the in advance of the meeting.
Scientific Review Officer, Research public in accordance with the
Technology and Contract Review Branch,
The meeting will be closed to the
provisions set forth in sections public in accordance with the
Division of Extramural Activities, National 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Cancer Institute, NIH, 9609 Medical Center provisions set forth in sections
Drive, Room 7W264, Bethesda, MD 20892–
as amended. The grant applications and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
9750, 240–276–6384, gravesr@mail.nih.gov. the discussions could disclose as amended. The grant applications and
(Catalogue of Federal Domestic Assistance confidential trade secrets or commercial the discussions could disclose
Program Nos. 93.392, Cancer Construction; property such as patentable material, confidential trade secrets or commercial
93.393, Cancer Cause and Prevention and personal information concerning property such as patentable material,
Research; 93.394, Cancer Detection and individuals associated with the grant and personal information concerning
Diagnosis Research; 93.395, Cancer applications, the disclosure of which individuals associated with the grant
Treatment Research; 93.396, Cancer Biology would constitute a clearly unwarranted
Research; 93.397, Cancer Centers Support;
applications, the disclosure of which
invasion of personal privacy. would constitute a clearly unwarranted
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health, Name of Committee: National Institute on invasion of personal privacy.
HHS) Alcohol Abuse and Alcoholism Initial
Name of Committee: National Heart, Lung,
Review Group, Clinical, Treatment and
Dated: January 30, 2018. and Blood Advisory Council.
Health Services Research Review Date: February 6, 2018.
Melanie J. Pantoja, Subcommittee. Open: 8:30 a.m. to 11:30 a.m.
Program Analyst, Office of Federal Advisory Date: March 23, 2018. Agenda: To discuss program policies and
Committee Policy. Time: 8:30 a.m. to 5:00 p.m. issues.
[FR Doc. 2018–02156 Filed 2–2–18; 8:45 am]
Agenda: To review and evaluate grant Place: National Institutes of Health,
applications. Building 35A, Porter Building, 35A Convent
BILLING CODE 4140–01–P Place: National Institutes of Health, Drive, Room 640, Bethesda, MD 20892.
National Institute on Alcohol Abuse and Closed: 11:30 a.m. to 4:00 p.m.
Alcoholism, 5635 Fishers Lane, Terrace Level Agenda: To review and evaluate grant
DEPARTMENT OF HEALTH AND Conference Room 508, Bethesda, MD 20892. applications.
HUMAN SERVICES Contact Person: Ranga V. Srinivas, Ph.D., Place: National Institutes of Health,
Chief, Extramural Project Review Branch, Building 35A, Porter Building, 35A Convent
National Institutes of Health National Institute on Alcohol Abuse and Drive, Room 640, Bethesda, MD 20892.
sradovich on DSK3GMQ082PROD with NOTICES

Alcoholism, National Institutes of Health, Contact Person: Laura K. Moen, Ph.D.,
National Cancer Institute Amended 5365 Fishers Lane, Room 2085, Rockville, Director, Division of Extramural Research
Notice of Meeting MD 20852, (301) 451–2067, srinivar@ Activities, National Heart, Lung, and Blood
mail.nih.gov. Institute, National Institutes of Health, 6701
Notice is hereby given of a change in (Catalogue of Federal Domestic Assistance Rockledge Drive, Room 7100, Bethesda, MD
the meeting of the National Cancer Program Nos. 93.271, Alcohol Research 20892, 301–435–0260 moenl@mail.nih.gov.
Advisory Board, February 13, 2018, 1:00 Career Development Awards for Scientists This notice is being published less than 15
p.m. to February 13, 2018, 4:00 p.m., and Clinicians; 93.272, Alcohol National days prior to the meeting due to the timing

VerDate Sep<11>2014 18:08 Feb 02, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\05FEN1.SGM 05FEN1

Document Created: 2018-02-03 01:24:40
Document Modified: 2018-02-03 01:24:40

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		February 23, 2018.
FR Citation		83 FR 5112

83 FR 5112 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 24 (February 5, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health